Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Living with hematologic cancer: Recommendations, solutions

Beth Faiman, PhD, MSN, APRN-BC, AOCN and Matthew Faiman, MD, MBC, FACP
Cleveland Clinic Journal of Medicine July 2017, 84 (7) 528-534; DOI: https://doi.org/10.3949/ccjm.84a.15159
Beth Faiman
Nurse Practitioner, Department of Hematology and Medical Oncology, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Matthew Faiman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Follow-up beyond routine screening

    AFTER HODGKIN LYMPHOMA AND ACUTE LYMPHOBLASTIC OR MYELOGENOUS LEUKEMIA5,30,33,36
    Risks
    Subsequent neoplasms and recurrence
    Cardiac disease (after chest radiation)
    Oral cancer, osteonecrosis (after azathioprine or radiation to the jaw)
    Osteoporosis
    Chronic pain, peripheral neuropathy, Raynaud phenomenon
    Pulmonary fibrosis, interstitial pneumonitis (after mediastinal radiation and high doses of bleomycin)
    Cataracts (after high doses of radiation to head)
    Bladder fibrosis, hemorrhagic cystitis, impaired kidney function, bladder cancer (after abdominal radiation)
    Esophageal strictures, gastroesophageal reflux disease, enterocolitis, bowel obstruction
    Infections
    Educate on sun exposure, signs of cancer, healthy high-fiber diet, avoidance of alcohol, smoking cessation, hand-washing, vaccination, avoidance of people with colds, need to report symptoms
    Screen
    For skin cancer every year
    Mammography every 2 years for women age 50 to 7437
    Colonoscopy every 5 years after age 35, or 10 years after abdominal radiation
    Echocardiography at baseline and periodically
    Annual liver screening with aspartate aminotransferase, alanine aminotransferase, and bilirubin for patients who received ≥ 3,000 cGy to upper abdomen, or received methotrexate, mercaptopurine, or thioguanine
    Dual-energy x-ray absorptiometry per World Health Organization recommendations
    Vaccinate against pneumococcus (PCV 13 for immunocompromised individuals),38 influenza (inactivated); live-attenuated virus vaccines (eg, herpes zoster, influenza) can be used with caution and in close contacts of cancer survivors; consider prompt antibiotics to cover gram-positive organisms in those with hypogammaglobulinemia, compromised immunity
    Monitor for relapse: computed tomography (CT) to evaluate response, then chest radiography or CT every 6 to 12 months for 2 to 5 years
    Specialist evaluation as appropriate
    FOR OLDER PATIENTS with chronic lymphocytic leukemia, acute myelogenous leukemia, multiple myeloma and non-Hodgkin lymphoma22,39
    Risks
    Early onset of diabetes (secondary to steroid use), hypertension (secondary to chemotherapy), osteoporosis (especially after multiple myeloma), cataracts (from steroids), and cardiovascular disease (especially with anthracycline and alkylating agent chemotherapy); reinforce healthy lifestyle, proper screening
    AFTER ALL CANCERS33,34
    Address educational issues, emotional issues, financial issues, chronic pain, cognitive function, sleep disorders, immunizations, and healthy lifestyle (smoking cessation, weight management, diet, exercise)
    • View popup
    TABLE 2

    Screening after hematopoietic cell transplant

    Cardiovascular risk-factor assessment
    Immune system
    If on chronic graft-vs-host disease prevention: gram-positive encapsulated organism prophylaxis, Pneumocystis carinii pneumonia prophylaxis, cytomegalovirus testing
    Revaccinate after stem cell transplant, yearly inactivated influenza vaccine
    Ocular clinical symptom evaluation, ocular fundus examination if previously abnormal
    Dental assessment
    Pulmonary
    Clinical pulmonary assessment
    Smoking avoidance counseling
    Pulmonary function testing if previously abnormal
    Chest radiography if previously abnormal
    Liver
    Liver enzyme testing if previously abnormal
    Serum ferritin testing if previously abnormal
    Kidney
    Blood pressure screening
    Urine protein screening
    Blood urea nitrogen and creatinine testing
    Muscle and connective tissue
    Evaluate for muscle weakness if on chronic graft-vs-host disease prevention
    Physical activity counseling and routine exercise
    Bone and spine
    Bone density testing (adult women, all allogeneic transplant recipients and patients at high risk for bone loss), reassess if previously abnormal
    Nervous system
    Clinical neurologic evaluation
    Evaluate for cognitive development
    Endocrine system
    Thyroid function testing
    Growth velocity in children
    Gonadal function assessment in prepubertal children and in adults if previously abnormal
    Skin self-examination and sun exposure counseling
    Gynecologic examination
    Secondary cancers
    Vigilance counseling and screening
    Psychosocial, financial, and quality-of-life clinical assessment, sexual function assessment
    • Based on information in references 30 and 32

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 84 (7)
Cleveland Clinic Journal of Medicine
Vol. 84, Issue 7
1 Jul 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Living with hematologic cancer: Recommendations, solutions
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Living with hematologic cancer: Recommendations, solutions
Beth Faiman, Matthew Faiman
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7) 528-534; DOI: 10.3949/ccjm.84a.15159

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Living with hematologic cancer: Recommendations, solutions
Beth Faiman, Matthew Faiman
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7) 528-534; DOI: 10.3949/ccjm.84a.15159
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • SURVIVORSHIP BEGINS AT DIAGNOSIS
    • EFFECTS OF HEMATOLOGIC CANCER AND ITS TREATMENT
    • THE PRIMARY CARE CLINICIAN AND SURVIVORSHIP CARE
    • COMPONENTS OF A SURVIVORSHIP CARE PLAN AND SELF-MANAGEMENT
    • INFORMATION TECHNOLOGY SOLUTIONS
    • EMERGING TECHNOLOGY: TELEMEDICINE, VIRTUAL VISITS
    • SURVEILLANCE FOR LATE TREATMENT EFFECTS
    • SURVIVORS NEED ONGOING CARE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-output heart failure from arteriovenous dialysis access: A structured approach to diagnosis and management
  • Direct oral anticoagulants: Challenging prescribing scenarios in everyday practice
  • IgA nephropathy: Update on pathogenesis and treatment
Show more Review

Similar Articles

Subjects

  • Oncology
  • Preventive Care

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire